Application 204575

Type
ANDA
Sponsor
AUROLIFE PHARMA LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001HYDROCODONE BITARTRATE AND IBUPROFENHYDROCODONE BITARTRATE; IBUPROFENTABLET;ORAL7.5MG;200MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
13107-004Hydrocodone Bitartrate and IbuprofenHydrocodone Bitartrate and IbuprofenAurolife Pharma, LLCANDACurrent
13107-004Hydrocodone Bitartrate and IbuprofenHydrocodone Bitartrate and IbuprofenAurolife Pharma, LLCANDACurrent
13107-004Hydrocodone Bitartrate and IbuprofenHydrocodone Bitartrate and IbuprofenAurolife Pharma, LLCANDACurrent
13107-004Hydrocodone Bitartrate and IbuprofenHydrocodone Bitartrate and IbuprofenAurolife Pharma, LLCANDACurrent
13107-004Hydrocodone Bitartrate and IbuprofenHydrocodone Bitartrate and IbuprofenAurolife Pharma, LLCANDACurrent
13107-004Hydrocodone Bitartrate and IbuprofenHydrocodone Bitartrate and IbuprofenAurolife Pharma, LLCANDACurrent
13107-004Hydrocodone Bitartrate and IbuprofenHydrocodone Bitartrate and IbuprofenAurolife Pharma, LLCANDACurrent
13107-004Hydrocodone Bitartrate and IbuprofenHydrocodone Bitartrate and IbuprofenAurolife Pharma, LLCANDACurrent
67296-1655Hydrocodone Bitartrate and IbuprofenHydrocodone Bitartrate and IbuprofenRedPharm Drug, Inc.ANDACurrent
67296-1655Hydrocodone Bitartrate and IbuprofenHydrocodone Bitartrate and IbuprofenRedPharm Drug, Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
76044ORIG 2023-11-02